Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,596
NCT03162653
Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
Phase: Phase 3
Role: Collaborator
Start: Mar 25, 2018
Completion: Jan 31, 2026
NCT04217421
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Start: Feb 14, 2020
Completion: Dec 31, 2028
NCT05682482
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
Start: Oct 7, 2022
Completion: Jan 31, 2028